These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5085708)

  • 1. Central nervous system effects of 6-aminodopamine and 6-hydroxydopamine.
    Blank CL; Murrill E; Adams RN
    Brain Res; 1972 Oct; 45(2):635-7. PubMed ID: 5085708
    [No Abstract]   [Full Text] [Related]  

  • 2. The biochemical and pharmacological properties of 6-aminodopamine: similarity with 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté LJ; Cohen G
    J Neurochem; 1973 Jul; 21(1):111-6. PubMed ID: 4720889
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of central effects of 6-aminodopamine and 6-hydroxydopamine on catecholamine levels.
    Oke A; Freeman R; Adams RN
    Eur J Pharmacol; 1974 Apr; 26(1):125-7. PubMed ID: 4831981
    [No Abstract]   [Full Text] [Related]  

  • 4. Central supersensitivity to norepinephrine and amphetamine following brain chemical sympathectomy by 6-hydroxydopamine.
    Blum K; Wallace JE; Schwertner HA; Meyer E; Morgan WW
    Life Sci; 1977 May; 20(10):1705-13. PubMed ID: 875616
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenaline, noradrenaline and dopamine levels in brain and heart after administration of 6-hydroxydopamine and guanethedine to newborn mice.
    Liuzzi A; Foppen FH; Angeletti PU
    Biochem Pharmacol; 1974 Mar; 23(6):1041-4. PubMed ID: 4824904
    [No Abstract]   [Full Text] [Related]  

  • 6. Central effects of 6-hydroxydopamine.
    Longo VG
    Behav Biol; 1973 Oct; 9(4):397-420. PubMed ID: 4200735
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.
    Kaplanski J; Nyakas C; van Delft AM; Smelik PG
    Neuroendocrinology; 1973-1974; 13(1):123-7. PubMed ID: 4779045
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of intraventricular administration of noradrenaline and dopamine on the levels of corticosterone in rats and denervation hypersensitivity resulting from intraventricular administration of 6-hydroxydopamine.
    Kawa A; Taniguchi Y; Mizuguchi K; Ryu S; Ariyama T; Kamisaki T; Koreeda F; Kanehisa T
    Life Sci; 1978 Sep; 23(9):991-7. PubMed ID: 703530
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation.
    Bourgoin S; Adrien J; Laguzzi RF; Dolphin A; Bockaert J; Hery F; Hamon M
    Brain Res; 1979 Jan; 160(3):461-78. PubMed ID: 421125
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective depletion of dopamine following O-methylation of 6-hydroxydopamine.
    Ho BT; Meyer AL; Taylor D
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):47-56. PubMed ID: 4734016
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment.
    Oke A; Keller R; Adams RN
    Brain Res; 1978 Jun; 148(1):245-50. PubMed ID: 656929
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.
    Hedreen JC; Chalmers JP
    Brain Res; 1972 Nov; 47(1):1-36. PubMed ID: 4345031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
    Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and evaluation of brain catecholamine depletion by N-alkyl derivatives of 6-aminodopamine.
    Nerland DE; Smissman EE
    J Med Chem; 1976 Jan; 19(1):163-4. PubMed ID: 1246038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degenerative effects of 6-aminodopamine and 6-hydroxydopamine on peripheral adrenergic nerves.
    Siggins GR; Forman DS
    Z Zellforsch Mikrosk Anat; 1973 Dec; 146(3):339-49. PubMed ID: 4544341
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 6-hydroxydopamine and 5,6-dihydroxytryptamine on the response of the coaxially stimulated guinea-pig ileum to morphine.
    Ward A; Takemori AE
    J Pharmacol Exp Ther; 1976 Oct; 199(1):124-30. PubMed ID: 978474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain noradrenergic systems as a prerequisite for developing tolerance to barbiturates.
    Tabakoff B; Yanai J; Ritzmann RF
    Science; 1978 Apr; 200(4340):449-51. PubMed ID: 565533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of the intraventricular injection of 6-hydroxydopamine on the sleep-waking cycle of the cat].
    Laguzzi R; Petitjean F; Pujol JF; Jouvet M
    Brain Res; 1972 Dec; 48():295-310. PubMed ID: 4345597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.